References
- Chattopadhyay A, Navab M, Hough G et al. A novel approach to oral apoA‑I mimetic therapy. J. Lipid Res. 54, 995–1010 (2013).
- Kadl A, Meher AK, Sharma PR et al. Identification of a novel macrophage phenotype that develops in response to atherogenic phospholipids via Nrf2. Circ. Res. 17, 737–746 (2010).
- Ramsden CE, Ringel A, Feldstein AE et al. Lowering dietary linoleic acid reduces bioactive oxidized linoleic acid metabolites in humans. Prostaglandins Leukot. Essent. Fatty Acids 87, 135–141 (2012).
- Spann NJ, Garmire LX, McDonald JG et al. Regulated accumulation of desmosterol integrates macrophage lipid metabolism and inflammatory responses. Cell 151, 138–152 (2012).
- Victor RG, Haley RW, Willett DL et al. The Dallas Heart Study: a population‑based probability sample for the multidisciplinary study of ethnic differences in cardiovascular health. Am. J. Cardiol. 93, 1473–1480 (2004).
- Romeo G, Kozlitina J, Xing C et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat. Genet. 40, 1461–1465 (2008).
- Kim C‑W, Moon, Y‑A, Park, S et al. Induced polymerization of mammalian acetyl‑CoA carboxylase by MIG12 provides a tertiary level of regulation of fatty acid synthesis. Proc. Natl Acad. Sci. USA 107(21), 9626–9631 (2010).
- Blankman JL, Cravatt BF. Chemical probes of endocannabinoid metabolism. Pharmacol. Rev. 65, 849–871 (2013).